Bartlett & Co’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bartlett & Co’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-800	Closed	-$10K	–	1107
2022 Q4	$10K	Hold	800	–	–	﹤0.01%	832
2022 Q3	$26K	Buy	+800	New	+$22.6K	﹤0.01%	669

Bartlett & Co's CINC Position: Q1 2023 in Review

Bartlett & Co sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 800 shares — an estimated $10K sold.

Bartlett & Co first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $26K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Bartlett & Co reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bartlett & Co sold 800 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $10K.
Bartlett & Co first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Bartlett & Co's CinCor Pharma, Inc. Common Stock position peaked at $26K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Bartlett & Co's 13F filing for Q1 2023, filed 6 Apr 2023.